MannKind Secures $500M Financing from Blackstone to Boost Biopharmaceutical Innovations
MannKind Corporation has announced a strategic financing agreement with Blackstone, potentially injecting up to $500 million into the company to accelerate its research and development efforts.
2 minutes to read

